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Illustration from:  http://www.cochrane.org/
SYSTEMATIC REVIEW: DEFINITION
“A systematic review attempts to collate all empirical evidence 
that fits pre-specified criteria in order to answer a specific 
research question. It uses explicit, systematic methods that are 
selected with a view to minimizing bias, thus providing more 
reliable findings from which conclusions can be drawn and 
decisions made”.
Many systematic reviews also contain meta-analysis, statistical 
methods to summarize the results of the identified studies. 
Cochrane Handbook for Systematic Reviews of Interventions (2011)
CONNECTED TO EVIDENCE BASED MEDICINE 
 The first formal guides for systematic review methods dates back to the 
mid-1970th (ePPI centre, 2016)
 Developed together of Evidenced Based Medicine in the mid-1990s 
 The Cochrane Collaboration formed in1993 (“Promote evidence-informed health 
decision-making by producing high-quality, relevant, accessible systematic reviews and 
other synthesized research evidence”)
 Gordon Gayatt: first to coin the term EBM in 1993
 The “father” of EBM: David Sackett (“Evidence based medicine: 
what it is and what it isn’t”, BMJ, 1996)
Image from BMJ 
THE EBM TRIAD 
Illustration from Sackett et al., 2000
SYSTEMATIC REVIEWS: BEST AVAILABLE EVIDENCE  
Illustration from Sackett et al., 2000
INCREASED NO. OF PUBLISHED SYSTEMATIC REVIEWS 
Source:SCOPUS
DOCUMENTS BY SUBJECT AREA 
Source:SCOPUS
SRS AND MAS AND EVIDENCED BASED PRACTICE
 Supports evidence-based clinical decision making 
 Informs local, national and international medical   
guidelines and policies 
 SRs before clinical trials to reduce research 
waste 
Image from Shutterstock
Evans I, Thornton H, Chalmers I, et al. Testing Treatments: Better Research for Better Healthcare. 
2nd edition. London: Pinter & Martin; 2011. Chapter 2, Hoped-for effects that don’t materialize.
CLINICAL IMPACT OF SYSTEMATIC REVIEWS
Example: Baby's sleep position
THE SYSTEMATIC REVIEW
PROCESS 
Illustration from:  http://www.cochrane.org/
Average time for a systematic 







 Mobile screening 
 Extract and analyze
www. covidence.org
ALL STEPS ON ONE PAGE 
EASY SCREENING FUNCTIONS 
REPORTING METHODS
STANDARDIZED REPORTING METHODS
1996- The Cochrane Handbook 
1999- QUROM (QUality Of Reporting Of Meta-analyses)
2000- MOOSE (Meta-analysis of observational studies in epidemiology) 
2009- PRISMA (Preferred Reporting Items for Systematic Reviews and Meta- analyses) 
2011- IOM (Institute of Medicines Standards for Systematic Reviews)
PRISMA
Preferred or required reporting method for:
 The Lancet
 The British Medical Journal (BMJ)
 Annals of Internal Medicine




 List of (27) preferred reporting 
items for SRs and MAs 
 Screening and selection 
flow diagram
 Help, tips and support
THE PRISMA CHECKLIST
Moher et al., 2009
THE PRISMA FLOW 
DIAGRAM
Moher et al., 2009
DETAILED AND REPRODUCIBLE SEARCH DOCUMENTATION 
 Database name, coverage 
and dates searched
 Search technical specifications
 Results from each source 
 MeSH/Thesaurus variations
PLAN AND STRUCTURE YOUR PROCESS WITH A 
PROTOCOL 
 Required standard item in PRISMA, Cochrane, IOM 
etc. for transparency of the research process
 The protocol can be published in a journal or in a
register/database
PROSPERO: REGISTER FOR ONGOING AND 
PUBLISHED SYSTEMATIC REVIEWS
 Provides a template for protocols
 Receive an official registration no.
for the review to submit to the journal
 Covers protocol items for different
standards (PRISMA, Cochrane...).
PRE-SEARCH FOR ONGOING AND PUBLISHED REVIEWS
SEARCH 
METHODOLOGY 
Image from Shutterstock 
THE FOUNDATION FOR MOST SRS AND MAS
(("Ampicillin Resistance"[Mesh] OR "Penicillin Resistance"[Mesh] OR "Tetracycline Resistance"[Mesh] OR "Drug Resistance, Bacterial"[Mesh] OR "Drug 
Resistance, Multiple, Bacterial"[Mesh] OR Resistan*[Title/Abstract]) AND ("H pylori"[Title/Abstract] OR "Helicobacter pylori"[Title/Abstract] OR "Helicobacter 
pylori"[Mesh] OR "Helicobacter Infections"[Title/Abstract] OR "Helicobacter Infection"[Title/Abstract] OR "Helicobacter Infections"[Mesh] 
OR"Campylobacter"[Mesh] OR Campylobacter [Title/Abstract]) AND (Rifabutin[Title/Abstract] OR Antibiotic*[Title/Abstract] OR Tinidazole[Title/Abstract] 
OR Doxycycline[Title/Abstract] OR Ampicillin[Title/Abstract] OR Moxifloxacin[Title/Abstract] OR Metronidazole[Title/Abstract] OR
Clarithromycin[Title/Abstract] OR Levofloxacin[Title/Abstract] OR Amoxicillin[Title/Abstract] OR “combination capsules”[Title/Abstract] OR “combination 
capsule”[Title/Abstract] OR “Sequential therapy”[Title/Abstract] OR "Quad therapy”[Title/Abstract] OR “Quadruple therapy"[Title/Abstract] OR “Triple 
therapy”[Title/Abstract] OR Penicillin*[Title/Abstract] OR Macrolide*[Title/Abstract] OR Rifamycin*[Title/Abstract] OR Nitroimidazole*[Title/Abstract] OR 
Quinolone*[Title/Abstract] OR Tetracycline*[Title/Abstract] OR Quinolinone*[Title/Abstract] OR "anti-bacterial agents"[Title/Abstract] OR "anti-bacterial 
agent"[Title/Abstract] OR amoxycillin[Title/Abstract] OR "Anti-Bacterial Agents"[Mesh] OR "Penicillins"[Mesh] OR "Macrolides"[Mesh] OR "Rifamycins"[Mesh] 
OR "Nitroimidazoles"[Mesh] OR "Quinolones"[Mesh] OR "Tetracyclines"[Mesh]) AND ("Republic of Cameron"[Title/Abstract] OR "Africa"[Mesh] OR “Sub 
Sahara”[Title/Abstract] OR “Sub Saharan”[Title/Abstract] OR Angola [Title/Abstract] OR Benin [Title/Abstract] OR Botswana [Title/Abstract] OR “Burkina 
Faso”[Title/Abstract] OR Burundi [Title/Abstract] OR Cameroon[Title/Abstract] OR “Cape Verde”[Title/Abstract] OR Chad[Title/Abstract] OR 
Congo[Title/Abstract] OR “Côte d'Ivoire”[Title/Abstract] OR “Ivory Coast”[Title/Abstract] OR Djibouti[Title/Abstract] OR “Equatorial Guinea”[Title/Abstract] 
OR Eritrea[Title/Abstract] OR Ethiopia[Title/Abstract] OR Gabon*[Title/Abstract] OR Gambia[Title/Abstract] OR Ghana[Title/Abstract] OR 
Guinea[Title/Abstract] OR “Guinea Bissau”[Title/Abstract] OR Kenya[Title/Abstract] OR Lesotho[Title/Abstract] OR Liberia[Title/Abstract] OR 
Malawi[Title/Abstract] OR Mali[Title/Abstract] OR Mauritania[Title/Abstract] OR Mozambique[Title/Abstract] OR Namibia[Title/Abstract] OR 
Niger[Title/Abstract] OR Nigeria[Title/Abstract] OR Rwanda[Title/Abstract] OR Senegal[Title/Abstract] OR “Sierra Leone”[Title/Abstract] OR 
Somalia[Title/Abstract] OR Sudan [Title/Abstract] OR Swaziland[Title/Abstract] OR Tanzania[Title/Abstract] OR Togo[Title/Abstract] OR 
Uganda[Title/Abstract] OR Zambia[Title/Abstract] OR Zimbabwe[Title/Abstract] OR Africa*[Title/Abstract] OR "Togolese Republic"[Title/Abstract] OR 
"Burkina Fasso"[Title/Abstract] OR "Upper Volta"[Title/Abstract] OR Zaire[Title/Abstract]))
A comprehensive, systematic search, with the aim to exhaust all available 
studies matching a specific research question and pre-set inclusion criteria
HIGH QUALITY SEARCH STRATEGIES 
Requires:
 Time
 Advanced skills in information retrieval, search techniques 
and information resources 
 Knowledge about medical terms and thesaurus/MeSH
indexing
 Detailed search term inclusion and testing
 Analysis of the search process
Deeks, Higgins, Altman, & Green 2011
THE SR TIMELINE
HIGH QUALITY SEARCH STRATEGIES 
Requires:
 Time
 Advanced skills in information retrieval, search techniques 
and information resources 
 Knowledge about medical terms and thesaurus/MeSH
indexing
 Detailed search term inclusion and testing
 Analysis of the search process





Small mistakes can lead 
to large variations
(((("weight reduction"[Title/Abstract] OR "weight management"[Title/Abstract] 
OR "weight control"[Title/Abstract] OR "weight reductions"[Title/Abstract] OR 
"weight loss"[Title/Abstract] OR "weight losses"[Title/Abstract] OR "Weight 
Loss"[Mesh])) AND (obesity[Title/Abstract] OR obese[Title/Abstract] OR 
obesities[Title/Abstract] OR "Obesity"[Mesh:NoExp]  OR "Obesity, 
Abdominal"[Mesh] OR "Obesity, Metabolically Benign"[Mesh] OR "Obesity 
Hypoventilation Syndrome"[Mesh] OR "Obesity, Morbid"[Mesh] OR 
BMI[Title/Abstract] OR "body mass index"[Title/Abstract] OR "Body Mass 
Index"[Mesh] OR "Overweight"[Mesh:NoExp] OR overweight[Title/Abstract])) 
AND (T2D[Title/Abstract] OR "diabetes type II"[Title/Abstract] OR "type 2 
diabetes"[Title/Abstract] OR "diabetes type 2"[Title/Abstract] OR 
T2DM[Title/Abstract] OR NIDDM[Title/Abstract] OR “diabetes mellitus, 
noninsulin-dependent”[Title/Abstract] OR “diabetes mellitus, non-Insulin-
dependent”[Title/Abstract] OR “non-insulin-dependent diabetes 
mellitus”[Title/Abstract] OR “diabetes mellitus, noninsulin 
dependent”[Title/Abstract] OR “diabetes mellitus, non insulin 
dependent”[Title/Abstract] OR “diabetes mellitus, type II”[Title/Abstract] OR 
“noninsulin-dependent diabetes mellitus”[Title/Abstract] OR "diabetes mellitus 
type 2"[Title/Abstract] OR diabesity[Title/Abstract] OR "Diabetes Mellitus, Type 
2"[Mesh:NoExp])) AND (("Costs and Cost Analysis"[Mesh] OR "Cost 
Savings"[Mesh] OR "Economics"[Mesh] OR "Health Care Costs"[Mesh] OR 
"Hospital Costs"[Mesh] OR "Health Expenditures"[Mesh] OR 
economic*[Title/Abstract] OR cost[Title/Abstract] OR costs[Title/Abstract] OR 
"Economics, Medical"[Mesh:NoExp] OR “burden of illness”[Title/Abstract] OR 
“Illness Burden”[Title/Abstract] OR utility[Title/Abstract] OR “life 
years”[Title/Abstract] OR “quality-adjusted life years”[Title/Abstract] OR 
“disability adjusted life years”[Title/Abstract] OR “cost-benefit 
analysis”[Title/Abstract] OR “cost-effectiveness analysis”[Title/Abstract] OR 
“cost-utility analysis”[Title/Abstract] OR “economic evaluation”[Title/Abstract] 
OR expenditure*[Title/Abstract] OR “illness Burdens”[Title/Abstract] OR 
"Models, Economic"[Mesh] OR "Cost of Illness"[Mesh]))
 374 out of 1120 references missed 
due to the lack of one “OR” operator
.
PEER REVIEW OF THE SEARCH STRING BEFORE 
SUBMITTING 
PRESS 
Evidence- based checklist for 
systematic searches 
Link: https://www.cadth.ca
SEARCH METHODOLOGY AND QUALITY IMPACT
 The search in many SRs and MAs are still of poor quality and includes a 
very high percentage (up to 93%) of search technical errors (Golder, Loke, & 
Zorzela, 2013; Grossetta et al. 2019; Koffel & Rethlefsen, 2016; Opheim et al. 2019; Rethlefsen et al. 
2015; Salvador-Oliván et al. 2019)
 Close connection between the quality of the search and method 
documentation and the quality and risk of bias of SRs and MAs (Golder, Loke, & 
Zorzela, 2013; Peters et al. 2015; Rethlefsen, Murad, & Livingston, 2014)
 Poor search documentation and lack of method transparency reduces 
usefulness of SRs and MAs in evidence based clinical settings (Golder, Loke, & 
McIntosh, 2008; Knehans, Dell & Robinson, 2016 Peters et al. 2015)
A SYSTEMATIC APPROACH
(("Ampicillin Resistance"[Mesh] OR "Penicillin Resistance"[Mesh] OR "Tetracycline Resistance"[Mesh] OR "Drug Resistance, Bacterial"[Mesh] OR "Drug 
Resistance, Multiple, Bacterial"[Mesh] OR Resistan*[Title/Abstract]) AND ("H pylori"[Title/Abstract] OR "Helicobacter pylori"[Title/Abstract] OR "Helicobacter 
pylori"[Mesh] OR "Helicobacter Infections"[Title/Abstract] OR "Helicobacter Infection"[Title/Abstract] OR "Helicobacter Infections"[Mesh] 
OR"Campylobacter"[Mesh] OR Campylobacter [Title/Abstract]) AND (Rifabutin[Title/Abstract] OR Antibiotic*[Title/Abstract] OR Tinidazole[Title/Abstract] 
OR Doxycycline[Title/Abstract] OR Ampicillin[Title/Abstract] OR Moxifloxacin[Title/Abstract] OR Metronidazole[Title/Abstract] OR
Clarithromycin[Title/Abstract] OR Levofloxacin[Title/Abstract] OR Amoxicillin[Title/Abstract] OR “combination capsules”[Title/Abstract] OR “combination 
capsule”[Title/Abstract] OR “Sequential therapy”[Title/Abstract] OR "Quad therapy”[Title/Abstract] OR “Quadruple therapy"[Title/Abstract] OR “Triple 
therapy”[Title/Abstract] OR Penicillin*[Title/Abstract] OR Macrolide*[Title/Abstract] OR Rifamycin*[Title/Abstract] OR Nitroimidazole*[Title/Abstract] OR 
Quinolone*[Title/Abstract] OR Tetracycline*[Title/Abstract] OR Quinolinone*[Title/Abstract] OR "anti-bacterial agents"[Title/Abstract] OR "anti-bacterial 
agent"[Title/Abstract] OR amoxycillin[Title/Abstract] OR "Anti-Bacterial Agents"[Mesh] OR "Penicillins"[Mesh] OR "Macrolides"[Mesh] OR "Rifamycins"[Mesh] 
OR "Nitroimidazoles"[Mesh] OR "Quinolones"[Mesh] OR "Tetracyclines"[Mesh]) AND ("Republic of Cameron"[Title/Abstract] OR "Africa"[Mesh] OR “Sub 
Sahara”[Title/Abstract] OR “Sub Saharan”[Title/Abstract] OR Angola [Title/Abstract] OR Benin [Title/Abstract] OR Botswana [Title/Abstract] OR “Burkina 
Faso”[Title/Abstract] OR Burundi [Title/Abstract] OR Cameroon[Title/Abstract] OR “Cape Verde”[Title/Abstract] OR Chad[Title/Abstract] OR 
Congo[Title/Abstract] OR “Côte d'Ivoire”[Title/Abstract] OR “Ivory Coast”[Title/Abstract] OR Djibouti[Title/Abstract] OR “Equatorial Guinea”[Title/Abstract] 
OR Eritrea[Title/Abstract] OR Ethiopia[Title/Abstract] OR Gabon*[Title/Abstract] OR Gambia[Title/Abstract] OR Ghana[Title/Abstract] OR 
Guinea[Title/Abstract] OR “Guinea Bissau”[Title/Abstract] OR Kenya[Title/Abstract] OR Lesotho[Title/Abstract] OR Liberia[Title/Abstract] OR 
Malawi[Title/Abstract] OR Mali[Title/Abstract] OR Mauritania[Title/Abstract] OR Mozambique[Title/Abstract] OR Namibia[Title/Abstract] OR 
Niger[Title/Abstract] OR Nigeria[Title/Abstract] OR Rwanda[Title/Abstract] OR Senegal[Title/Abstract] OR “Sierra Leone”[Title/Abstract] OR 
Somalia[Title/Abstract] OR Sudan [Title/Abstract] OR Swaziland[Title/Abstract] OR Tanzania[Title/Abstract] OR Togo[Title/Abstract] OR 
Uganda[Title/Abstract] OR Zambia[Title/Abstract] OR Zimbabwe[Title/Abstract] OR Africa*[Title/Abstract] OR "Togolese Republic"[Title/Abstract] OR 
"Burkina Fasso"[Title/Abstract] OR "Upper Volta"[Title/Abstract] OR Zaire[Title/Abstract]))
SYSTEMATIC REVIEW SEARCH







Jaka et al., 2018 

H-PYLORI AND ANTIBIOTIC RESISTANCE 
IN SUB SAHARA 
(("Ampicillin Resistance"[Mesh] OR "Penicillin Resistance"[Mesh] OR "Tetracycline Resistance"[Mesh] OR "Drug Resistance, Bacterial"[Mesh] OR "Drug 
Resistance, Multiple, Bacterial"[Mesh] OR Resistan*[Title/Abstract]) AND ("H pylori"[Title/Abstract] OR "Helicobacter pylori"[Title/Abstract] OR 
"Helicobacter pylori"[Mesh] OR "Helicobacter Infections"[Title/Abstract] OR "Helicobacter Infection"[Title/Abstract] OR "Helicobacter Infections"[Mesh] 
OR"Campylobacter"[Mesh] OR Campylobacter [Title/Abstract]) AND (Rifabutin[Title/Abstract] OR Antibiotic*[Title/Abstract] OR Tinidazole[Title/Abstract] 
OR Doxycycline[Title/Abstract] OR Ampicillin[Title/Abstract] OR Moxifloxacin[Title/Abstract] OR Metronidazole[Title/Abstract] OR
Clarithromycin[Title/Abstract] OR Levofloxacin[Title/Abstract] OR Amoxicillin[Title/Abstract] OR “combination capsules”[Title/Abstract] OR “combination 
capsule”[Title/Abstract] OR “Sequential therapy”[Title/Abstract] OR "Quad therapy”[Title/Abstract] OR “Quadruple therapy"[Title/Abstract] OR “Triple 
therapy”[Title/Abstract] OR Penicillin*[Title/Abstract] OR Macrolide*[Title/Abstract] OR Rifamycin*[Title/Abstract] OR Nitroimidazole*[Title/Abstract] OR 
Quinolone*[Title/Abstract] OR Tetracycline*[Title/Abstract] OR Quinolinone*[Title/Abstract] OR "anti-bacterial agents"[Title/Abstract] OR "anti-bacterial 
agent"[Title/Abstract] OR amoxycillin[Title/Abstract] OR "Anti-Bacterial Agents"[Mesh] OR "Penicillins"[Mesh] OR "Macrolides"[Mesh] OR 
"Rifamycins"[Mesh] OR "Nitroimidazoles"[Mesh] OR "Quinolones"[Mesh] OR "Tetracyclines"[Mesh]) AND ("Republic of Cameron"[Title/Abstract] OR 
"Africa"[Mesh] OR “Sub Sahara”[Title/Abstract] OR “Sub Saharan”[Title/Abstract] OR Angola [Title/Abstract] OR Benin [Title/Abstract] OR Botswana 
[Title/Abstract] OR “Burkina Faso”[Title/Abstract] OR Burundi [Title/Abstract] OR Cameroon[Title/Abstract] OR “Cape Verde”[Title/Abstract] OR 
Chad[Title/Abstract] OR Congo[Title/Abstract] OR “Côte d'Ivoire”[Title/Abstract] OR “Ivory Coast”[Title/Abstract] OR Djibouti[Title/Abstract] OR 
“Equatorial Guinea”[Title/Abstract] OR Eritrea[Title/Abstract] OR Ethiopia[Title/Abstract] OR Gabon*[Title/Abstract] OR Gambia[Title/Abstract] OR 
Ghana[Title/Abstract] OR Guinea[Title/Abstract] OR “Guinea Bissau”[Title/Abstract] OR Kenya[Title/Abstract] OR Lesotho[Title/Abstract] OR 
Liberia[Title/Abstract] OR Malawi[Title/Abstract] OR Mali[Title/Abstract] OR Mauritania[Title/Abstract] OR Mozambique[Title/Abstract] OR 
Namibia[Title/Abstract] OR Niger[Title/Abstract] OR Nigeria[Title/Abstract] OR Rwanda[Title/Abstract] OR Senegal[Title/Abstract] OR “Sierra 
Leone”[Title/Abstract] OR Somalia[Title/Abstract] OR Sudan [Title/Abstract] OR Swaziland[Title/Abstract] OR Tanzania[Title/Abstract] OR 
Togo[Title/Abstract] OR Uganda[Title/Abstract] OR Zambia[Title/Abstract] OR Zimbabwe[Title/Abstract] OR Africa*[Title/Abstract] OR "Togolese 
Republic"[Title/Abstract] OR "Burkina Fasso"[Title/Abstract] OR "Upper Volta"[Title/Abstract] OR Zaire[Title/Abstract]))
Jaka et al., 2018 

HBA1C
“Hb A1c” OR “A1C” OR “GHb” OR “HbA1c” OR “HbA1” 
OR “Hb A1” OR “Hb-A1c” OR “hemoglobin A1c” OR 
“hemoglobin A1” OR “haemoglobin A1c” OR 
“haemoglobin A1c” OR “glycohemoglobin” OR “glyco
hemoglobin” OR “glycohemoglobins” OR 
“glycohaemoglobin” OR “glyco haemoglobin” OR 
“glycohaemoglobins” OR “hemoglobin A(1)” OR 
“haemoglobin A(1)” OR “glycosylated hemoglobin” OR 
“glycosylated hemoglobins” OR “glycosylated 
haemoglobin” OR “glycosylated haemoglobins” OR 
“glycated hemoglobins” OR “glycated hemoglobin” OR 
“glycated haemoglobins” OR “glycated haemoglobin”
Image from Shutterstock

THE SYSTEMATIC SEARCH PROCESS 




 Systematic developing and testing the search in 
one selected database
 Translate the search to all selected databases 





RULE NO. 1: KEEP IT “SIMPLE”
Search one term at the time and concentrate on 
search term inclusion, combinations and process 
analysis rather than database functions  
FOCUS ON THE 
SEARCH TERMS
Is there a relation between diabetes 
type 2 in children and food habits
Type 2 diabetes Food Exercise Health 
information
Diabetes type 2 Food intake Sport Patient education
Type 2 diabetes Nutrition Activity Patient learning
Diabetes Mellitus 
type 2









Advanced vs Basic Search 
Advanced search: 
- You have full control over the search= high precision
- Advanced search functions available including 
search history and field search 
Basic search: 
- PubMed interprets your search= low precision





 Truncation (Child*= child, children, children’s…)
 Phrasing (“myocardial infarction”)
 Field search (Title, Abstract, MeSH)
 Boolean operators (AND, OR, NOT)
 Search history (helps you structure and combine)
SEARCH EXAMPLE: ANIMAL
Image from Duke University 
OPTIMIZE YOUR SEARCH BY COMBINING TI/AB AND MESH
MeSH/Thesaurus terms can take 2 months 













Web of Science 
Other databases
 CINAHL
 Psych Info/Psych Articles
 Africa Wide Information



























HAND SEARCHING AND REFERENCE SCREENING
 Screening of references in identified articles
 Screening of archived/printed materials or
conference abstracts.
 Make sure to systematically conduct and 
documented the hand screening in the 
methodology (method, inclusion, number of 













on the effect of 













review to assess 
the relationship 
between sleep 
duration and mood 
in adolescents





7880 3424 6242 1157 1381
Total no. of 
references after 
de-duplication 
9324 1816 4321 1120 1532




47,3% 17,3 % 66,4% 53,7% 49%
INCLUDE A VARIETY OF INFORMATION RESOURCES
COMPREHENSIVENESS VS UP-TO-DATE
GOOGLE SCHOLAR FOR SYSTEMATIC REVIEWS? 
 Great for pre and post search scanning 
 Lacks proper search tools
 Generates too many (irrelevant) references – a lot to screen
 A good search in selected databases should cover all 
relevant information available in Google Scholar  
 Includes more predatory journals
INVOLVING A MEDICAL LIBRARIAN
.  
Guidelines like IOM and the Cochrane’s Handbook 
recommends that a professional medical librarian 
develops the search strategy and preforms and document 
the search process
SRs and MAs with a librarian included as a co- author,  
are generally of higher quality (search and 
documentation) compared to studies only supported by a 
librarian or without a librarian’s involvement (Meert & Costella, 
2016; Rethlefsen et al., 2015)
Reduces the risk of bias 
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